Monday, March 2, 2015
FAIRFIELD-SUISUN, CALIFORNIA
99 CENTS

Merck to pay $3.85B for hepatitis C drug developer

Merck

FILE - This Thursday, Feb. 28, 2013 file photo shows a patch with the Merck logo on a scientist's lab coat in West Point, Pa. Merck on Monday, June 9, 2014 announced it will spend nearly $4 billion for Idenix Pharmaceuticals with a per-share bid that more than triples the hepatitis C drug developer’s latest closing price. (AP Photo/Matt Rourke, File)

By
June 10, 2014 |

TRENTON, N.J. — Merck & Co. will spend about $3.85 billion for Idenix Pharmaceuticals Inc., a small company developing hepatitis C medicines that, together with Merck’s experimental drugs, could produce lucrative combo therapies that quickly cure most patients with the blood-borne virus afflicting tens of millions.

The price for the deal announced Monday — a per-share bid more than triple Friday’s closing price for Cambridge, Massachusetts-based Idenix — seems high. However, the latest hepatitis C medicines command very high prices, the number of patients keeps rising and Merck was bidding against rivals.

Hepatitis C has become one of the hottest categories in drug research as companies race to develop a combination therapy without injections and debilitating side effects. Some have had their promising candidates fail after extensive testing, due to dangerous side effects, but Gilead Sciences Inc. is already raking in billions of dollars from its groundbreaking new drug, Sovaldi.

Merck, based in Whitehouse Station, New Jersey, said it will spend $24.50 in cash for each Idenix share. Idenix closed at $7.23 on Friday, then more than tripled at Monday’s opening bell.

The boards of both companies have approved the deal, which should close in the third quarter.

“Idenix has established a promising portfolio of hepatitis C candidates based on its expertise in (certain) technologies,” Merck’s research head, Dr. Roger Perlmutter, said in a statement.

Three Idenix experimental drugs have reached human testing and one, samatasvir, is in mid-stage testing. It’s in a new drug class called NS5A inhibitors, which disrupt various stages of the virus life cycle. Two other drugs, known as IDX21437 and IDX21459, are in a class called nucleotide prodrugs, which stop the virus from producing genetic material needed to copy itself.

Merck has been testing two drugs together, MK-5172 and MK-8742, that the Food and Drug Administration has deemed a breakthrough therapy. Merck will soon start late-stage testing of the two drugs together and presumably will study them in combinations with the Idenix drugs.

About 4.4 million Americans and an estimated 170 million people worldwide have chronic hepatitis C, the leading cause of liver cancer and, in wealthy countries, the top reason for liver transplants. In the U.S., it kills more than 16,000 people a year.

While most people infected don’t know it because there are no obvious symptoms, a growing number have been identified and started treatment in the last few years as more effective medicines have been approved. That number is expected to grow as the U.S. population ages and patients infected decades ago through intravenous drug use, or from blood transfusions before the early 1990s, are diagnosed.

Merck has been a major player in hepatitis C since acquiring Schering-Plough in 2009. Back then, treatment was limited to twice-a-day pills called ribavirin and self-injections of a long-acting, synthetic form of immune system protein interferon. Treatment often lasted 48 weeks, only about 40 percent of patients were cured, and flu-like symptoms and other side effects of the interferon kept many patients from completing treatment.

In 2011, the FDA approved two drugs in a class called protease inhibitors, Merck’s Victrelis and Incivek from Vertex Pharmaceuticals. Those are taken with ribavirin and interferon, work by blocking an enzyme needed for copying the virus, and boost the cure rate to about 75 percent. But they require patients to take a dozen pills a day, and still endure flu-like side effects.

Last December, the FDA approved Gilead’s once-a-day pill Sovaldi, which cures 80 percent to 90 percent of patients, without the interferon injections and side effects.

Physicians quickly embraced it, and Sovaldi racked up more than $2 billion in sales in its first full quarter on sale, considered the best new drug launch in history. That’s mainly because of Sovaldi’s high price, about $1,000 per pill, or $84,000 for a 12-week treatment course, which continues to draw criticism from patients, insurers and government.

Sovaldi appears poised to dominate the hepatitis C market, greatly outselling Johnson & Johnson’s Olysio, approved about the same time. But there’s plenty of room for Merck and others because Sovaldi can’t be taken by some patients with multiple illnesses or certain hepatitis C subtypes.

In afternoon trading, Idenix shares climbed $16.76 to $23.99. Merck shares slipped 5 cents to $57.80.

Shares of another hepatitis C drug developer, Achillion Pharmaceuticals Inc., now seen as a potential takeover target, climbed 58 percent to $4.55.

 

The Associated Press

The Associated Press

LEAVE A COMMENT

Discussion | No comments

The Daily Republic does not necessarily condone the comments here, nor does it review every post. Read our full policy

  • Recent Articles

  • Enter your email address to subscribe and receive notifications of new posts by email.

  • .

    Solano News

    Whiteside ready to take Travis school board seat

    By Bill Hicks | From Page: A1 | Gallery

     
    World War II spy shares tales of work behind enemy lines

    By Amy Maginnis-Honey | From Page: A1 | Gallery

    I love to ‘read’ audiobooks

    By Tony Wade | From Page: A2

     
    Council to hear budget scenarios

    By Amy Maginnis-Honey | From Page: A3

    Sessions on Suisun water rate increases to start

    By Susan Hiland | From Page: A3

     
    Fairfield High School celebrates black history

    By Susan Hiland | From Page: A3

    Warm winter afternoon at Lagoon Valley Park

    By Steve Reczkowski | From Page: A3 | Gallery

     
    Free medical series targets senior health issues

    By Susan Hiland | From Page: A3

    Pena Adobe hosts natural dye-making presentation

    By Susan Hiland | From Page: A3

     
    PublicStuff, an online app, set for Fairfield

    By Ryan McCarthy | From Page: A3

     
    Beginning gardening series starts in March

    By Susan Hiland | From Page: A3

    Literacy celebration returns this month

    By Susan Hiland | From Page: A3

     
    Shell casings, but no victims found on Del Sur Court

    By Amy Maginnis-Honey | From Page: A3

    Vacaville 4-alarm house fIre

    By Steve Reczkowski | From Page: A4 | Gallery

     
    IHOP takes part in National Pancake Day

    By Susan Hiland | From Page: A4

    Local governments schedule meetings this week

    By Susan Hiland | From Page: A4

     
    Weather for Monday, March 2, 2015

    By Daily Republic staff | From Page: B10

    Corner Store Gallery schedules open house

    By Susan Hiland | From Page: A10

     
    .

    US / World

    Kerry tries to dampen fuss over Israeli PM’s speech

    By The Associated Press | From Page: A1

     
    Hundreds of bills introduced by California lawmakers

    By The Associated Press | From Page: A1

    Lawmakers tinker with crime measure recently OK’d by voters

    By The Associated Press | From Page: A1

     
    Storm brings rain, thunder, hail to Southern California

    By The Associated Press | From Page: A4

    California GOP recognizes gay faction of party

    By The Associated Press | From Page: A4

     
    Family backs mom of infant found dead along California river

    By The Associated Press | From Page: A4

    Survey: Parents increasingly ask doctors to delay vaccines

    By The Associated Press | From Page: A5

     
    Newspaper: Nurse who survived Ebola says hospital failed her

    By The Associated Press | From Page: A5

    Myanmar captures rare white elephant in western jungles

    By The Associated Press | From Page: A5

     
    Crowd kills girl suspected to be suicide bomber in Nigeria

    By The Associated Press | From Page: A5

    New plane tracking to be tested after Malaysia jet mystery

    By The Associated Press | From Page: A5

     
    Iraqi premier gives ultimatum ahead of hinted Tikrit attack

    By The Associated Press | From Page: A5

    Activists say Islamic State releases 19 Syrian Christians

    By The Associated Press | From Page: A5

     
    Sierra Leone’s vice president in quarantine for Ebola

    By The Associated Press | From Page: A5

    30,000 marchers in Moscow mourn slain Putin foe

    By The Associated Press | From Page: A5

     
    Spacewalking astronauts finish extensive, tricky cable job

    By The Associated Press | From Page: A5

    .

    Opinion

    Your right to work for less

    By Mike Kirchubel | From Page: A8

     
    Right fight in DC, but wrong reason

    By Colbert I. King | From Page: A8

    Editorial Cartoon: March 2, 2015

    By Daily Republic Syndicated Content | From Page: A8

     
    A night with a King

    By Delon Jackson | From Page: A8

     
    .

    Living

    Today in History: March 2, 2015

    By The Associated Press | From Page: A2

     
    Community Calendar: March 2, 2015

    By Susan Hiland | From Page: A2

    Why timeouts only prolong the problem

    By The Washington Post | From Page: B5

     
    Horoscopes: March 3, 2015

    By Holiday Mathis | From Page: B5

    Horoscopes: March 2, 2015

    By Holiday Mathis | From Page: A7

     
    It’s never a good idea to point out how big a pregnant woman is

    By Kathy Mitchell and Marcy Sugar | From Page: A7

    .

    Entertainment

     
    Will Smith’s ‘Focus’ tops box office with $19.1 million

    By The Associated Press | From Page: B6

    Lady Gaga, Vince Vaughn take charity polar plunge in Chicago

    By The Associated Press | From Page: B6

     
    TVGrid March 2

    By Daily Republic Syndicated Content | From Page: A10

    TVGrid March 3

    By Daily Republic Syndicated Content | From Page: B11

     
    .

    Sports

    Lillard, Aldridge lead Blazers past Kings for 3rd in a row

    By The Associated Press | From Page: B1

     
    Curry scores 37, leads Warriors from 26 down to beat Celtics

    By The Associated Press | From Page: B1 | Gallery

     
    Jimmie Johnson pulls away for another Atlanta Sprint Cup win

    By The Associated Press | From Page: B1 | Gallery

    Giants reliever Strickland insists he’s tranquil on mound

    By The Associated Press | From Page: B1

     
    Former Washington basketball star Christian Welp dies at 51

    By The Associated Press | From Page: B2

    Sharks trade Sheppard to Rangers for draft pick

    By The Associated Press | From Page: B2

     
    4,000 attend Jerry Tarkanian tribute in Las Vegas arena

    By The Associated Press | From Page: B2

    Garnett buys 1,000 tickets for fans for next T-wolves game

    By The Associated Press | From Page: B2

     
    Poulter, Casey share lead at rain-delayed Honda Classic

    By The Associated Press | From Page: B2

    Blatter concerned by Russian soccer racism before World Cup

    By The Associated Press | From Page: B2

     
    Broadcasters propose FIFA election debate to Blatter, rivals

    By The Associated Press | From Page: B2

    Major league baseball’s 1st black Latino star Minoso dies

    By The Associated Press | From Page: B2 | Gallery

     
    Seller’s market for NHL teams as trade deadline nears

    By The Associated Press | From Page: B2

    Andy Sullivan wins Joburg Open for 2nd title this year

    By The Associated Press | From Page: B2

     
    South Korea’s Amy Yang wins Honda LPGA Thailand

    By The Associated Press | From Page: B2

    Hannah hurls Bulldogs to 2-0 win over Campolindo

    By Daily Republic staff | From Page: B2

     
    Oregon women upset No. 19 Stanford 62-55

    By The Associated Press | From Page: B2

    Indians open season with 12-4 win over Falcons

    By Daily Republic staff | From Page: B2

     
    Oregon beats Stanford 73-70, clinches bye in Pac-12 tourney

    By The Associated Press | From Page: B2

    Process gets underway to carve up $60 million Sandusky fine

    By The Associated Press | From Page: B2

     
    Cal’s big run lifts Bears past Oregon State 73-56

    By The Associated Press | From Page: B2

     
    This date in sports history for March 2, 2015

    By The Associated Press | From Page: B3

    Yankees’ Alex Rodriguez nearing 1st spring game

    By The Associated Press | From Page: B7

     
    Fast and furious: Rousey looks to future after 14-second win

    By The Associated Press | From Page: B7 | Gallery

    .

    Business

    Samsung ditches plastic design, adds mobile pay in new phone

    By The Associated Press | From Page: A10

     
    In Apple’s latest update, emojis get diverse

    By The Associated Press | From Page: A10

    Mimi’s adds breakfast items to menu

    By Susan Hiland | From Page: A10

     
    .

    Obituaries

    Lester Singer

    By Nancy Green | From Page: A4

     
    Jacqueline Mendes

    By Nancy Green | From Page: A4

    .

    Comics

    Garfield March 3

    By Daily Republic Syndicated Content | From Page: B4

     
    Sally Forth March 3

    By Daily Republic Syndicated Content | From Page: B4

    Get Fuzzy March 3

    By Daily Republic Syndicated Content | From Page: B4

     
    Frank and Ernest March 3

    By Daily Republic Syndicated Content | From Page: B4

    Dilbert March 3

    By Daily Republic Syndicated Content | From Page: B4

     
    Beetle Bailey March 3

    By Daily Republic Syndicated Content | From Page: B4

    Blondie March 3

    By Daily Republic Syndicated Content | From Page: B4

     
    For Better or Worse March 3

    By Daily Republic Syndicated Content | From Page: B4

    Wizard of Id March 3

    By Daily Republic Syndicated Content | From Page: B4

     
    Pickles March 3

    By Daily Republic Syndicated Content | From Page: B4

    Peanuts March 3

    By Daily Republic Syndicated Content | From Page: B4

     
    B.C. March 3

    By Daily Republic Syndicated Content | From Page: B4

    Baby Blues March 3

    By Daily Republic Syndicated Content | From Page: B4

     
    Rose is Rose March 3

    By Daily Republic Syndicated Content | From Page: B4

    Baldo March 3

    By Daily Republic Syndicated Content | From Page: B4

     
    Zits March 3

    By Daily Republic Syndicated Content | From Page: B4

    Cryptoquote March 3

    By Daily Republic Syndicated Content | From Page: B5

     
    Word Sleuth March 3

    By Daily Republic Syndicated Content | From Page: B5

    Bridge March 3

    By Daily Republic Syndicated Content | From Page: B5

     
    Crossword March 3

    By Daily Republic Syndicated Content | From Page: B5

    Sudoku March 3

    By Daily Republic Syndicated Content | From Page: B5

     
    For Better or Worse March 2

    By Daily Republic Syndicated Content | From Page: A6

    Dilbert March 2

    By Daily Republic Syndicated Content | From Page: A6

     
    Baldo March 2

    By Daily Republic Syndicated Content | From Page: A6

    Zits March 2

    By Daily Republic Syndicated Content | From Page: A6

     
    Rose is Rose March 2

    By Daily Republic Syndicated Content | From Page: A6

    Pickles March 2

    By Daily Republic Syndicated Content | From Page: A6

     
    Garfield March 2

    By Daily Republic Syndicated Content | From Page: A6

    Get Fuzzy March 2

    By Daily Republic Syndicated Content | From Page: A6

     
    Frank and Ernest March 2

    By Daily Republic Syndicated Content | From Page: A6

    Blondie March 2

    By Daily Republic Syndicated Content | From Page: A6

     
    Sally Forth March 2

    By Daily Republic Syndicated Content | From Page: A6

    Wizard of Id March 2

    By Daily Republic Syndicated Content | From Page: A6

     
    Baby Blues March 2

    By Daily Republic Syndicated Content | From Page: A6

    B.C. March 2

    By Daily Republic Syndicated Content | From Page: A6

     
    Beetle Bailey March 2

    By Daily Republic Syndicated Content | From Page: A6

    Peanuts March 2

    By Daily Republic Syndicated Content | From Page: A6

     
    Sudoku March 2

    By Daily Republic Syndicated Content | From Page: A7

    Bridge March 2

    By Daily Republic Syndicated Content | From Page: A7

     
    Word Sleuth March 2

    By Daily Republic Syndicated Content | From Page: A7

    Crossword March 2

    By Daily Republic Syndicated Content | From Page: A7

     
    Cryptoquote March 2

    By Daily Republic Syndicated Content | From Page: A7